Abrdn plc grew its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 48.2% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 106,106 shares of the medical research company’s stock after purchasing an additional 34,494 shares during the period. abrdn plc […]
Motley Fool Asset Management LLC lessened its holdings in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. Motley […]
Motley Fool Asset Management LLC cut its position in Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 9.6% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,931 shares of the medical research company’s stock after selling 310 shares during the quarter. […]
Xponance Inc. decreased its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 5.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,405 shares of the medical research company’s stock after selling 668 shares during the […]
Hussman Strategic Advisors Inc. grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 400.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,500 shares of the medical research company’s stock after buying an additional 25,200 shares […]